ASTRAZENECA PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 13.4%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 13.4%
Tue, 22 Sep

ASTRAZENECA PHARMA has announced its results for the quarter ended June 2020. Here is a detailed performance review of the same:

ASTRAZENECA PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-19*
3
Mar-20*
3
Jun-20*
QoQ ChangeYoY Change
Net SalesRs m2,0461,9491,936-0.7%-5.4%
Other incomeRs m303426-21.6%-11.4%
TurnoverRs m2,0761,9831,962-1.0%-5.5%
ExpensesRs m1,6901,8011,650-8.4%-2.4%
Gross profitRs m35614828692.9%-19.7%
DepreciationRs m4645460.4%-1.4%
InterestRs m333-4.2%-7.1%
Profit before taxRs m33613426497.6%-21.5%
TaxRs m1213878105.4%-36.0%
Profit after taxRs m2159618694.5%-13.4%
Gross profit margin%17.47.614.8
Effective tax rate%36.028.329.4
Net profit margin%10.44.89.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 5.4% on a year-on-year (YoY) basis. The expenses were down by 2.4% YoY during the same period.
  • The company's operating profit declined by 19.7% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 14.8% in 1QFY21 as against 17.4% in 1QFY20.
  • Depreciation charges declined by 1.4% and finance costs declined by 7.1% YoY, respectively.
  • Other income declined by 11.4% YoY during the quarter.
  • Net profit for the quarter declined by 13.4% YoY. Net profit margins during the quarter declined from 10.4% in 1QFY20 to 9.5% in 1QFY21.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 0.7% on a quarter-on-quarter (QoQ) basis. The expenses were down by 8.4% QoQ during the same period.
  • The company's operating profit increased by 92.9% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 14.8% in 1QFY21 as against 7.6% in 4QFY20.
  • Net profit for the quarter increased by 94.5% QoQ, while net profit margins increased from 4.8% in 4QFY20 to 9.5% in 1QFY21.

To see how ASTRAZENECA PHARMA has performed over the last eight quarters,please visit here.

ASTRAZENECA PHARMA Share Price Performance

Over the last one year, ASTRAZENECA PHARMA share price has moved up from Rs 2,048.8 to Rs 4,286.5, registering a Gain of Rs 2,237.7 or around 109.2%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 19,200.0 (down 2.1%). Over the last one year it has moved up from 13,016.6 to 19,200.0, a gain of 6,183 points (up 47.5%).

Overall, the S&P BSE SENSEX is up 3.3% over the year.

Current Valuations

At the current price of Rs 4,286.5, the price to earnings (P/E) ratio of ASTRAZENECA PHARMA stands at 154.6 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 43.4 times.

Equitymaster requests your view! Post a comment on "ASTRAZENECA PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 13.4%". Click here!

  

Related Views on News

ASTRAZENECA PHARMA Announces Quarterly Results (3QFY21); Net Profit Down 21.2% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 211 m (down 21.2% YoY). Sales on the other hand came in at Rs 2 bn (down 10.5% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 2.5% (Quarterly Result Update)

May 20, 2020 | Updated on May 20, 2020

For the quarter ended March 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 96 m (down 2.5% YoY). Sales on the other hand came in at Rs 2 bn (up 2.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Mar 29, 2019 | Updated on Mar 29, 2019

Here's an analysis of the annual report of ASTRAZENECA PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ASTRAZENECA PHARMA. Also includes updates on the valuation of ASTRAZENECA PHARMA.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ASTRAZENECA PHARMA SHARE PRICE


Feb 26, 2021 (Close)

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA 8-QTR ANALYSIS

COMPARE ASTRAZENECA PHARMA WITH

MARKET STATS